• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.

作者信息

Houyau P, Gay C, Chatelut E, Canal P, Roché H, Milano G

出版信息

J Natl Cancer Inst. 1993 Oct 6;85(19):1602-3. doi: 10.1093/jnci/85.19.1602.

DOI:10.1093/jnci/85.19.1602
PMID:8411234
Abstract
摘要

相似文献

1
Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
J Natl Cancer Inst. 1993 Oct 6;85(19):1602-3. doi: 10.1093/jnci/85.19.1602.
2
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta.
Eur J Cancer. 1996 Feb;32A(2):369-70. doi: 10.1016/0959-8049(95)00573-0.
3
Severe 5-fluorouracil toxicity in a patient with decreased dihydropyrimidine dehydrogenase activity.
Cancer Invest. 1993;11(2):239-40. doi: 10.3109/07357909309024846.
4
Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil associated toxicity.
Adv Exp Med Biol. 2000;486:251-5. doi: 10.1007/0-306-46843-3_49.
5
[Severe 5-fluorouracil toxicity in a woman treated for breast cancer with concurrent osteogenesis imperfecta and dehydrogenase deficiency].
Bull Cancer. 1996 Apr;83(4):324-7.
6
[Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity].
Rev Med Interne. 2000 Dec;21(12):1134-5. doi: 10.1016/s0248-8663(00)00278-2.
7
Dihydropyrimidine dehydrogenase deficiency: a potential etiology for 5-fluorouracil-induced neurotoxicity.
Pharmacotherapy. 1997 Jul-Aug;17(4):847-8; discussion 849.
8
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.二氢嘧啶脱氢酶缺乏症与氟尿嘧啶相关毒性
Br J Cancer. 1999 Feb;79(3-4):627-30. doi: 10.1038/sj.bjc.6690098.
9
Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency.二氢嘧啶脱氢酶缺乏患者接受基于5-氟尿嘧啶的化疗后出现严重神经毒性。
Clin Cancer Res. 1996 Mar;2(3):477-81.
10
Population characteristics of hepatic dihydropyrimidine dehydrogenase activity, a key metabolic enzyme in 5-fluorouracil chemotherapy.
Clin Pharmacol Ther. 1995 Nov;58(5):512-22. doi: 10.1016/0009-9236(95)90171-X.

引用本文的文献

1
and Fluorouracil-Based Chemotherapy: Mini Review and Case Report.以及基于氟尿嘧啶的化疗：综述与病例报告
Pharmaceutics. 2019 May 1;11(5):199. doi: 10.3390/pharmaceutics11050199.
2
How may anticancer chemotherapy with fluorouracil be individualised?氟尿嘧啶的抗癌化疗如何实现个体化？
Clin Pharmacokinet. 2006;45(6):567-92. doi: 10.2165/00003088-200645060-00002.
3
Phase I study of eniluracil, oral 5-fluororacil and gemcitabine in patients with advanced malignancy.恩尿嘧啶、口服5-氟尿嘧啶和吉西他滨用于晚期恶性肿瘤患者的I期研究。
Invest New Drugs. 2002 Nov;20(4):377-82. doi: 10.1023/a:1020673928704.
4
The oral fluorinated pyrimidines.口服氟嘧啶类药物。
Invest New Drugs. 2001;19(1):41-59. doi: 10.1023/a:1006404701008.
5
Clinical pharmacokinetics of capecitabine.卡培他滨的临床药代动力学
Clin Pharmacokinet. 2001;40(2):85-104. doi: 10.2165/00003088-200140020-00002.
6
Pharmacogenetics: a tool for individualizing antineoplastic therapy.药物遗传学：一种实现抗肿瘤治疗个体化的工具。
Clin Pharmacokinet. 2000 Nov;39(5):315-25. doi: 10.2165/00003088-200039050-00001.
7
Pharmacology of fluorinated pyrimidines: eniluracil.氟嘧啶类药物的药理学：依诺尿嘧啶。
Invest New Drugs. 2000 Nov;18(4):373-81. doi: 10.1023/a:1006453500629.
8
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.二氢嘧啶脱氢酶缺乏症与氟尿嘧啶相关毒性
Br J Cancer. 1999 Feb;79(3-4):627-30. doi: 10.1038/sj.bjc.6690098.
9
Practical treatment guide for dose individualisation in cancer chemotherapy.癌症化疗剂量个体化实用治疗指南。
Drugs. 1998 Dec;56(6):1019-38. doi: 10.2165/00003495-199856060-00006.
10
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.结直肠癌患者的二氢嘧啶脱氢酶药物遗传学
Br J Cancer. 1998;77(3):497-500. doi: 10.1038/bjc.1998.79.